Efficacy of administering remimazolam at anesthetic management for awake craniotomy

Not Applicable

Recruiting

• Conditions: Brain tumor

• Registration Number: JPRN-jRCT1041200094
• Lead Sponsor: ishiwaki Kimitoshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-01-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Patients who undergo elective awake craniotomy

Exclusion Criteria

1)Patients who do not agree.
2)have a liver disfunction(Child-pugh classification B or higher).
3)have an allergy for the ropivacaine and other anesthetics drugs.
4)have an obvious hemostatic dysfunction(Platelet count of 80000 or less,PT-INR of 1.5 or more,APTT of 40 seconds or more).
5)have a severe respiratory disorder(%VC<60%,orFEV1%<50%).
6)have a primary closed angle glaucoma
7)have a heart failure (ejection fraction of 45% or less on echocardiography, presence of severe valvular disease, and past history of coronary artery disease).
8)patient who can not be in candidate at this study decided by the doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified